GlassScriptPhysician profile
Ryan Michael Mccracken
NPI 1255652277
$2,322.37
in general payments reported to CMS, 2019-2025
16 companies · $604 in 2025
The $604 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.94 · 2020: $34.49 · 2021: $208 · 2022: $294 · 2023: $555 · 2024: $528 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,686.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $731.59 | 2021-2025 | Azstarys, Azstarys |
| Supernus Pharmaceuticals, INC. | $500.36 | 2021-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $206.97 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $173.72 | 2022-2025 | |
| Tris Pharma INC | $160.72 | 2022-2025 | Dyanavel Xr |
| Sanofi Pasteur INC. | $92.21 | 2020-2025 | |
| Collegium Pharmaceutical, INC. | $83.06 | 2025 | Jornay Pm |
| Seqirus USA INC | $66.46 | 2022-2025 | Flucelvax |
| Merck Sharp & Dohme LLC | $51.05 | 2023-2024 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Sobi, INC | $50.27 | 2019-2023 | |
| Ultragenyx Pharmaceutical INC. | $46.01 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.78 | 2021 | |
| Glaxosmithkline, LLC. | $41.70 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $34.37 | 2024-2025 | Relexxii |
| Adlon Therapeutics L.P. | $22.73 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $17.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mccracken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.